Kathleen (“Kat”) Brown’s practice stretches across a broad range of areas in the highly regulated health care space.
Kat routinely assists clients in identifying and navigating potential regulatory pitfalls, including federal and state anti-referral laws, fee splitting and corporate practice of medicine (CPOM) laws, and HIPAA compliance and breach responses. She also counsels clients with questions related to licensure and practitioner scope of practice; pharmacy and wholesale distribution establishment and regulatory compliance; and pharmaceutical drug and device distribution chain questions. Kat also regularly performs health care diligence in large transactions, such as mergers and acquisitions.
Kat’s practice also involves working with nonprofits and charitable organizations at each phase of their lifecycle, from formation, application for federal tax exemption, and registration with state charities bureaus to day-to-day operations and ongoing corporate governance, including assisting organizations to implement policies to comply with their legal and fiduciary duties, inclusive of conflict of interest, whistleblower, and investment policies.
Prior to joining the firm, Kat developed her health care knowledge through her diverse experiences working in private practice, New York State government, government relations, and health care consulting. From that experience, Kat has developed a valuable understanding of the regulatory landscape impacting all provider types, enabling her to effectively and successfully advocate for her clients at all levels of government.
Garfunkel Wild received prominent recognition in the 2025 editions of The Best Lawyers in America and The Best Lawyers in America: Ones to Watch. A total of 38 attorneys were honored with 59 individual recognitions across various practices and offices nationwide.
Thirty-Eight Garfunkel Wild attorneys were selected by their peers for inclusion in the 2024 editions of The Best Lawyers in America and The Best Lawyers: Ones to Watch.
Thirty-Three Garfunkel Wild attorneys were selected by their peers for inclusion in 2022 New York Metro Super Lawyers, and 2022 New York Metro/Upstate New York Rising Stars.
Thirty-Six Garfunkel Wild attorneys were selected by their peers for inclusion in 2021 New York Metro Super Lawyers, and 2021 New York Metro/Upstate New York Rising Stars.
Garfunkel Wild, P.C., a premier law firm with a specialty in health law, is pleased to announce the formal launch of the firm’s multi-disciplinary Cannabis Law Practice Group to help clients navigate the rapidly evolving cannabis landscape and conflicting federal, state, and local laws and regulations.
Thirty-Six Garfunkel Wild attorneys were selected by their peers for inclusion in 2020 New York Metro Super Lawyers, and 2020 New York Metro/Upstate Rising Stars.
On October 12, 2024, the New York State Department of Health (“DOH”) published the final cybersecurity regulations for general hospitals (the “Regulations”), with some provisions effective immediately.
Andrew E. Blustein and Kathleen M. Brown will present "Compliance and Governance: Maintaining Operational Excellence for FQHCs" at the 2024 New Jersey Primary Care Association (“NJPCA”) Annual Conference, on October 10th.
The U.S. Department of Health and Human Services, Office of Inspector General (“OIG”) released a Report outlining concerns about the rapid growth of and significant oversight gaps in the Centers for Medicare & Medicaid’s (“CMS”) use of remote patient monitoring (“RPM”) services, particularly with traditional Medicare patients (the “Report”). Given RPM’s dramatic growth, especially since the COVID-19 pandemic, the Report likely foreshadows OIG enforcement actions in this area.
On May 15, 2024, the New York State Department of Health (DOH) announced a pivotal change in its regulations, as it intends to permit health care providers to use telemedicine to conduct patient evaluations before prescribing controlled substances. Prior to the COVID-19 pandemic, DOH required health care providers to perform an initial in-person physical evaluation of patients before prescribing controlled substances.
The HIPAA Privacy Rule to Support Reproductive Health Care Privacy was recently announced as a final rule that becomes effective on June 25, 2024 (the “Final Rule”).
On March 9, 2024, CMS announced it will make available Change Healthcare/Optum Payment Disruption accelerated payments to providers experiencing potentially significant cash-flow problems as a result of the cyberattack on UnitedHealth Group’s subsidiary Change Healthcare/Optum .
Additional speaking & writing
Publications
Authored chapters entitled "Immunizations" and "Issues Involving Infectious Diseases" in the Legal Manual for New York Physicians (Sixth Edition)